Pharma Pipeline Intelligence MCP Server
Pricing
from $350.00 / 1,000 full pipeline threat reports
Pharma Pipeline Intelligence MCP Server
Drug pipeline MCP wrapping 7 actors. Clinical trials, adverse events, patent exclusivity, FDA/EMA regulatory pathways, drug recalls, literature momentum. Pipeline Threat Score 0-100. Pay-per-event.
Pricing
from $350.00 / 1,000 full pipeline threat reports
Rating
0.0
(0)
Developer

ryan clinton
Actor stats
0
Bookmarked
2
Total users
1
Monthly active users
20 hours ago
Last modified
Categories
Share
Drug pipeline and competitive landscape intelligence via MCP. Orchestrates 7 data sources for clinical trial tracking, adverse event signal detection, patent exclusivity monitoring, regulatory pathway comparison, and drug recall monitoring. Produces Pipeline Threat Scores (0-100).
Tools
| Tool | Price | Description |
|---|---|---|
search_drug_pipeline | $2.00 | Search active clinical trials by drug, condition, or sponsor |
analyze_competitive_landscape | $2.00 | Analyze competitive landscape for a therapeutic area or molecule |
detect_adverse_event_signals | $2.00 | Detect adverse event signal divergence from FDA FAERS data |
track_patent_exclusivity | $2.00 | Track patent exclusivity windows and upcoming expirations |
compare_regulatory_pathways | $2.00 | Compare FDA vs EMA regulatory pathways and approval timelines |
monitor_drug_recalls | $2.00 | Monitor drug recalls and safety communications |
assess_literature_momentum | $2.00 | Assess publication momentum and research interest via PubMed |
generate_pipeline_threat_report | $5.00 | Comprehensive pipeline threat report with competitive scoring |
Data Sources
This MCP orchestrates 7 Apify actors:
- Clinical Trial Tracker — ClinicalTrials.gov study data
- openFDA Drug Events — FDA Adverse Event Reporting System (FAERS)
- FDA Drug Approvals — NDA/BLA/ANDA approval data
- FDA Drug Recalls — Drug recall and safety alerts
- PubMed Search — Biomedical literature search
- USPTO Patent Search — Pharmaceutical patent filings
- EMA Medicines — European Medicines Agency product data
Scoring Models
- Pipeline Threat Score (0-100): Competitive threat level based on Phase 3 trial density, recent approvals in therapeutic area, adverse event signals for competitors, and patent cliff proximity
- First-Mover Advantage Index: Time-to-market advantage based on trial phase progression vs competitors
- Adverse Event Signal Divergence: Detects statistically unusual adverse event patterns vs background rate
- Literature Momentum Score: Publication velocity and citation acceleration in therapeutic area
How to Connect
Claude Desktop
{"mcpServers": {"pharma-pipeline": {"url": "https://pharma-pipeline-intelligence-mcp.apify.actor/mcp"}}}
Use Cases
- Pharma Business Development: Competitive landscape monitoring for licensing and partnership decisions
- Biotech Investors: Pipeline risk assessment for investment thesis validation
- Medical Affairs: Literature momentum tracking and adverse event signal detection
- Patent Strategy: Exclusivity window monitoring and generic entry risk assessment
FAQ
Q: How current is the clinical trial data? A: Clinical trial data is fetched live from ClinicalTrials.gov, which is updated by sponsors. There may be a lag of days to weeks depending on sponsor reporting.
Q: Does this replace pharmacovigilance systems? A: No. This provides signal detection from public FDA FAERS data. It complements but does not replace enterprise pharmacovigilance systems.
Q: Is it legal to use this? A: All data sources are public databases (FDA, NIH, USPTO, EMA). See Apify's guide on web scraping legality.
Related MCPs
- ryanclinton/product-safety-consumer-risk-mcp — Consumer product safety and recall intelligence
- ryanclinton/research-integrity-screening-mcp — Academic fraud and publication quality